Medicare Benefits Schedule - Item 15900

Breast, malignant tumour, targeted intraoperative radiation therapy, using an Intrabeam® or Xoft® Axxent® device, delivered at the time of breast‑conserving surgery (partial mastectomy or lumpectomy) for a patient who:

(a) is 45 years of age or over; and

(b) has a T1 or small T2 (less than or equal to 3 cm in diameter) primary tumour; and

(c) has a histologic grade 1 or 2 tumour; and

(d) has an oestrogen‑receptor positive tumour; and

(e) has a node negative malignancy; and

(f) is suitable for wide local excision of a primary invasive ductal carcinoma that was diagnosed as unifocal on conventional examination and imaging; and

(g) has no contra‑indications to breast irradiation

Applicable once per breast per lifetime (H)

Fee: $291.60 Benefit: 75% = $218.70

• Previous - Item 14288
• Next - Item 15902